Journal Article Summary

The article discusses a case involving a pregnant woman with severe early-onset fetal growth restriction (FGR), a condition that affects a small percentage of pregnancies and often leads to poor outcomes for the fetus. The authors explore the use of tadalafil, a medication typically used for conditions like erectile dysfunction and pulmonary hypertension, as a potential treatment for this serious issue. This topic is significant because there are limited effective treatments for FGR, and the ability to improve fetal growth could have a substantial impact on neonatal health.

In this case, a 41-year-old woman began taking tadalafil at 22 weeks of pregnancy after being diagnosed with severe FGR and oligohydramnios (low amniotic fluid). Within ten days of starting the medication, improvements were observed, including an increase in amniotic fluid and fetal weight. The baby was delivered via cesarean section at 32 weeks, weighing 1024 grams, and showed positive health indicators, suggesting that tadalafil may have helped improve the fetal environment and growth.

However, the study has limitations, primarily that it is based on a single case, making it difficult to draw broad conclusions about the effectiveness and safety of tadalafil for treating FGR. There is a need for more extensive research to understand the potential risks and benefits fully. Patients and caregivers should discuss this treatment option with healthcare professionals, considering the current lack of established protocols and the need for further studies to confirm the findings and assess long-term effects.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Sakamoto Mito, Osato Kazuhiro, Kubo Michiko, Nii Masafumi, Tanaka Hiroaki, Murabayashi Nao, Umekawa Takashi, Kamimoto Yuki, et al.. Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report. Journal of Medical Case Reports 2016. DOI: 10.1186/s13256-016-1098-x. PMID: 27821175. PMCID: PMC5100077.

Featured Pill Pals Product

Pill PalsĀ® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your medsā„¢. As a Pharmacy Benefits Management organization, Pill PalsĀ® gives patients the best cash prices on all meds. Pill PalsĀ® is part of The Health PalsĀ® Company (Health PalsĀ®, Med PalsĀ®, Skin PalsĀ® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]